About Policy Submissions

We regularly make submissions to national level inquiries. If you are after a submission from earlier than listed here, please contact us.

5 March 2019
Consumers Health Forum

At the heart of CHF’s policy agenda is patient-centred care. Our responses to the TGA’s consultation has been formed with a patient-centred approach in mind.
CHF notes that this consultation’s scope is limited to the regulatory guidance in line with existing regulatory requirements, and not...Read more

4 March 2019
Consumers Health Forum

CHF appreciates the opportunity to provide a comment in response to proposed changes to a number of definitions and the scope of the medical device regulatory framework in Australia.
At the heart of CHF’s policy agenda is patient-centred care. Our responses to the TGA’s consultation...Read more

2 January 2019
Consumers Health Forum

This submission is prepared in the context of an imminent federal election. CHF will be putting out an election priorities document which sets out our proposed agenda for health reform for through to 2025.Read more

13 November 2018
Consumers Health Forum

CHF is committed to the National Medicines Policy and in ensuring that all Australians have access to high quality, safe medicines and that all medicines should be used in line with the principles of the quality use of medicines.

CHF is keen to ensure the scheduling process is used to...Read more

15 October 2018
Consumers Health Forum

CHF welcomed the Review of Medicines and Medical Device Regulation. Whilst we did not support all the recommended approach of removing the required pre-approval of therapeutic goods advertisements to a complaints-based system, we are pleased to work with the Therapeutic Goods Administration (TGA...Read more

27 September 2018
Consumers Health Forum

CHF applauds the PSA’s renewed commitment to quality, safety, and meeting evolving community needs. We support the PSA’s intention to expand pharmacist roles but feel that this discussion paper has focused too much on community pharmacists and has overlooked the possibilities for hospital and...Read more

10 September 2018

The Australian Medical Research Advisory Board sought reflections and feedback on the first set of priorities for the Medical Research Future Fund (the MRFF) via a survey. This submission details CHF’s responses to the key questions in the survey.Read more

7 August 2018
Consumers Health Forum

Our focus in this response is health data, as that is our area of expertise and interest. As recognised in the issues paper, health data is more sensitive than data about most other areas of a consumers’ lives, such as personal preference for transport to work or even more sensitive data like...Read more

20 July 2018
Consumers Health Forum

CHF welcomed the Review of Medicines and Medical Device Regulation and, while we did not support removing the required pre-approval of therapeutic goods advertisements, we are pleased to work with the Therapeutic Goods Administration (TGA) to ensure that new arrangements will continue to protect...Read more

2 July 2018
Consumers Health Forum

CHF has consistently advocated123 for a national, whole-of-society obesity strategy. This is because recent reports show that years of public education campaigns have failed to reverse the rise in obesity, showing that it is well past time for individual-oriented prevention to become a priority...Read more

Pages